The connection between AF and stroke

5x

Patients with AF are five times more likely to have a stroke.1

 

40%

AF-related stroke carries a 40% higher risk of severe stroke and mortality than non-AF related stroke.2

10%–40%

Asymptomatic AF varies from 10% to 40% depending on the patient population.3

30%

Approximately 30% of AF is paroxysmal in patients with known AF.4



Symptoms are not a reliable indicator of AF,3 and short-term and intermittent cardiac monitoring may miss many patients with paroxysmal AF.5,6



The link between AF and stroke

Watch clinicians discuss the importance of long-term cardiac monitoring to detect AF and prevent secondary stroke.



Make a diagnosis, faster.†,7–10


When patients have unexplained or intermittent symptoms, 30 days of monitoring may not be sufficient. The LINQ™ family of ICMs (Reveal LINQ™ ICM and LINQ II™ ICM) work continuously to capture comprehensive and actionable data over a longer period of time than short-term monitors to deliver superior yield that can increase the rate of diagnosis of unknown AF.


84.5%

Clinical evidence shows 84.5% of patients at high risk of stroke and AF would have had their AF diagnosis missed with a single-use, 30-day monitor.‡,11



See the clinical evidence.

STROKE AF study

Review the results of this study, which evaluated the use of ICMs for AF detection in large- and small-vessel stroke patients.


REVEAL AF study

Explore the results of this study, which evaluated continuous, long-term monitoring with Reveal LINQ™ ICM for patients at high risk for atrial fibrillation and stroke.


CRYSTAL-AF study

Discover how Reveal LINQ™ ICM compared to standard monitoring for atrial fibrillation detection in cryptogenic stroke patients.




Manage AF with data-guided decisions.

The LINQ™ family of ICMs provides physicians with longitudinal data to objectively determine both asymptomatic and symptomatic AF. This data results in the measure of true AF burden and accurate characterization of the AF type to effectively guide therapy decisions.12,13





What is AF burden?

Watch clinicians explain AF burden and why it’s important when managing AF patients.




For how long should an AF patient be monitored?

Watch clinician experts share best practices based on their experience managing AF patients and explain why long-term monitoring is beneficial for AF.





Continuous cardiac monitoring leads to more actionable events than conventional monitoring.14

69%

of patients had at least one AF recurrence.15

46%

of the recurrent AF being asymptomatic15


The LINQ™ family of ICMs allows physicians to continually monitor the ongoing change in AF burden so treatment can be initiated or changed on a timely basis.16–18

Arrhythmia management allows for:

  • Case planning guidance
  • Symptom-rhythm correlation
  • Assessment of drug therapy
  • Objective measurement of AF burden
  • Determination of therapy success (e.g., post-AF ablation cardioversion)

CareAlert™ notifications§

Allow for customization by clinic and/or individual patient.

  • AF of any duration
  • AF burden
  • Ventricular rate
  • Symptom and auto detect
  • Ventricular rate during AF burden


Accuracy matters.


Discover the LINQ™ family of ICMs with AccuRhythm™ AI algorithms.

When you need answers, trust the most accurate ICM on the market.19–31 Our proven ICMs deliver the data you need to make the right diagnosis for your patients.32

The LINQ™ family of ICMs provides data that physicians may use to guide medical management decisions, including the titration of anticoagulation.18, 33–35

Detection algorithms

Maintain high detection sensitivity while reducing false episode review burden.36

 

Proven technology

1,000+ published clinical articles and abstracts32


Small, discrete implant37

One-third the size of a AAA battery (1.2 cc)

 

Fast, safe procedure

< 5 minutes insertion time38,39






What data do you capture with the LINQ II™ ICM?

Watch clinicians share the types of data and information they are able to access from the LINQ II™ ICM.




Related products